- Home
- MYPS vs RCEL Comparison
MYPS vs RCEL Comparison
Compare MYPS & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYPS
- RCEL
- Stock Information
- Founded
- MYPS 2011
- RCEL N/A
- Country
- MYPS United States
- RCEL United States
- Employees
- MYPS N/A
- RCEL N/A
- Industry
- MYPS EDP Services
- RCEL Medical/Dental Instruments
- Sector
- MYPS Technology
- RCEL Health Care
- Exchange
- MYPS Nasdaq
- RCEL Nasdaq
- Market Cap
- MYPS 121.6M
- RCEL 113.7M
- IPO Year
- MYPS N/A
- RCEL N/A
- Fundamental
- Price
- MYPS $0.97
- RCEL $4.56
- Analyst Decision
- MYPS Buy
- RCEL Strong Buy
- Analyst Count
- MYPS 5
- RCEL 4
- Target Price
- MYPS $2.50
- RCEL $13.75
- AVG Volume (30 Days)
- MYPS 229.4K
- RCEL 286.8K
- Earning Date
- MYPS 11-03-2025
- RCEL 11-06-2025
- Dividend Yield
- MYPS N/A
- RCEL N/A
- EPS Growth
- MYPS N/A
- RCEL N/A
- EPS
- MYPS N/A
- RCEL N/A
- Revenue
- MYPS $261,058,000.00
- RCEL $74,884,000.00
- Revenue This Year
- MYPS N/A
- RCEL $28.23
- Revenue Next Year
- MYPS N/A
- RCEL $35.24
- P/E Ratio
- MYPS N/A
- RCEL N/A
- Revenue Growth
- MYPS N/A
- RCEL 38.32
- 52 Week Low
- MYPS $0.90
- RCEL $3.60
- 52 Week High
- MYPS $2.29
- RCEL $14.16
- Technical
- Relative Strength Index (RSI)
- MYPS 40.45
- RCEL 46.58
- Support Level
- MYPS $0.94
- RCEL $4.12
- Resistance Level
- MYPS $0.98
- RCEL $4.44
- Average True Range (ATR)
- MYPS 0.03
- RCEL 0.25
- MACD
- MYPS 0.01
- RCEL 0.03
- Stochastic Oscillator
- MYPS 21.49
- RCEL 50.00
About MYPS PLAYSTUDIOS Inc.
PLAYSTUDIOS Inc is engaged in gaming and related business. The Company develops and operates online and mobile social gaming applications (games or game), many of which incorporate a loyalty program offering real world rewards provided by a collection of awards partners. The Company's games are free-to-play and available via the Apple App Store, Google Play Store, Amazon Appstore and Facebook (collectively, platforms or platform operators). The Company creates games based on its own original content as well as third-party licensed brands. The Company generates revenue through the in-game sales of virtual currency and through advertising. The company has one operating segment with one business activity, developing and monetizing social games.
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.